Susquehanna Fundamental Investments LLC acquired a new stake in shares of Globe Life Inc. (NYSE:GL - Free Report) during the 4th quarter, according to its most recent 13F filing with the SEC. The firm acquired 10,711 shares of the company's stock, valued at approximately $1,194,000.
A number of other hedge funds have also recently bought and sold shares of GL. Wellington Management Group LLP increased its position in shares of Globe Life by 6.8% during the fourth quarter. Wellington Management Group LLP now owns 5,117,122 shares of the company's stock valued at $570,661,000 after acquiring an additional 326,307 shares during the last quarter. Invesco Ltd. increased its position in shares of Globe Life by 6.0% during the 4th quarter. Invesco Ltd. now owns 3,932,637 shares of the company's stock valued at $438,568,000 after purchasing an additional 223,282 shares during the last quarter. Dimensional Fund Advisors LP raised its stake in shares of Globe Life by 8.0% during the 4th quarter. Dimensional Fund Advisors LP now owns 1,592,734 shares of the company's stock worth $177,615,000 after purchasing an additional 118,054 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in shares of Globe Life by 2.9% in the 4th quarter. Arrowstreet Capital Limited Partnership now owns 1,284,322 shares of the company's stock worth $143,228,000 after buying an additional 36,051 shares during the last quarter. Finally, Nuance Investments LLC grew its position in Globe Life by 8.3% during the fourth quarter. Nuance Investments LLC now owns 1,234,069 shares of the company's stock valued at $137,623,000 after buying an additional 95,091 shares during the period. 81.61% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling
In other news, CEO James Matthew Darden sold 24,890 shares of the firm's stock in a transaction on Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total transaction of $3,024,632.80. Following the sale, the chief executive officer now owns 38,973 shares in the company, valued at approximately $4,735,998.96. This trade represents a 38.97 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, CEO Frank M. Svoboda sold 11,000 shares of Globe Life stock in a transaction on Thursday, February 13th. The stock was sold at an average price of $122.31, for a total transaction of $1,345,410.00. Following the sale, the chief executive officer now directly owns 18,948 shares of the company's stock, valued at $2,317,529.88. This represents a 36.73 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.51% of the stock is currently owned by company insiders.
Globe Life Price Performance
NYSE GL traded down $0.31 during trading hours on Monday, hitting $121.52. The company had a trading volume of 524,391 shares, compared to its average volume of 917,473. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.05 and a current ratio of 0.05. The firm has a market capitalization of $10.12 billion, a price-to-earnings ratio of 10.17 and a beta of 0.56. Globe Life Inc. has a 52 week low of $76.55 and a 52 week high of $133.76. The firm has a 50 day simple moving average of $124.02 and a 200 day simple moving average of $116.84.
Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings data on Wednesday, April 30th. The company reported $3.07 EPS for the quarter, missing analysts' consensus estimates of $3.24 by ($0.17). The firm had revenue of $1.48 billion during the quarter, compared to the consensus estimate of $1.49 billion. Globe Life had a net margin of 18.53% and a return on equity of 22.32%. Globe Life's revenue was up 4.5% compared to the same quarter last year. During the same quarter last year, the business posted $2.78 earnings per share. Equities research analysts expect that Globe Life Inc. will post 13.87 earnings per share for the current year.
Globe Life Dividend Announcement
The company also recently declared a quarterly dividend, which will be paid on Friday, August 1st. Stockholders of record on Thursday, July 3rd will be issued a $0.27 dividend. The ex-dividend date is Thursday, July 3rd. This represents a $1.08 annualized dividend and a dividend yield of 0.89%. Globe Life's payout ratio is currently 8.79%.
Analyst Ratings Changes
A number of research analysts have weighed in on the stock. JPMorgan Chase & Co. boosted their target price on shares of Globe Life from $136.00 to $145.00 and gave the company an "overweight" rating in a research note on Wednesday, April 2nd. Keefe, Bruyette & Woods upped their price objective on Globe Life from $137.00 to $145.00 and gave the company an "outperform" rating in a research note on Wednesday, February 12th. Piper Sandler decreased their target price on Globe Life from $152.00 to $147.00 and set an "overweight" rating for the company in a research report on Friday. Evercore ISI upgraded Globe Life from an "in-line" rating to an "outperform" rating and boosted their target price for the company from $132.00 to $143.00 in a research note on Wednesday, January 8th. Finally, BMO Capital Markets initiated coverage on Globe Life in a research note on Thursday, January 23rd. They set a "market perform" rating and a $114.00 price target for the company. Four equities research analysts have rated the stock with a hold rating, six have issued a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, Globe Life currently has a consensus rating of "Moderate Buy" and a consensus target price of $137.09.
Get Our Latest Analysis on Globe Life
Globe Life Company Profile
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also

Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report